APP下载

熊去氧胆酸辅助治疗婴儿胆汁淤积症的效果观察

2020-09-02胡海燕

中外医学研究 2020年21期
关键词:治疗效果

胡海燕

【摘要】 目的:观察分析熊去氧胆酸辅助治疗婴儿胆汁淤积症的效果。方法:选取2018年8月-2019年7月在笔者所在医院接受治疗的70例胆汁淤积症患儿作为研究对象,采取随机分组的方式将其分为对照组(35例)与研究组(35例),对照组采取常规保肝药治疗,研究组在对照组基础上采取熊去氧胆酸辅助治疗,分析两组患儿治疗前后的肝生化指标变化、治疗效果及不良反应发生率。结果:研究组治疗后,治疗有效率为91.43%,明显高于对照组的80.00%,差异有统计学意义(P<0.05);两组治疗前DBIL、TBIL、ALT、AST等指标比较,差异无統计学意义(P>0.05),治疗后两组DBIL、TBIL、ALT、AST等指标明显下降,研究组下降程度明显优于对照组(P<0.05);两组均未出现严重不良反应,研究组不良反应发生率与对照组比较,差异无统计学意义(P>0.05)。结论:婴儿胆汁淤积症采取熊去氧胆酸辅助治疗能有效提高治疗效果,促进肝功能恢复,安全又可靠,值得临床推广。

【关键词】 熊去氧胆酸 婴儿 胆汁淤积症 治疗效果

doi:10.14033/j.cnki.cfmr.2020.21.013 文献标识码 B 文章编号 1674-6805(2020)21-00-03

Effect of Ursodeoxycholic Acid in the Treatment of Cholestasis in Infants/HU Haiyan. //Chinese and Foreign Medical Research, 2020, 18(21): -34

[Abstract] Objective: To observe the therapeutic effect of Ursodeoxycholic Acid on infant of cholestasis. Method: A total of 70 infant with cholestasis were treated in our hospital from August 2018 to July 2019 who were selected as the study objects. They were randomly divided into the control group (35 cases) and the study group (35 cases). The control group was treated with routine liver protection drugs, and the study group was treated with Ursodeoxycholic Acid on the basis of the control group. The changes of liver biochemistry of the two groups before and after treatment, therapeutic effect and incidence of adverse reactions were analyzed. Result: After treatment, the effective rate of 91.43% in the study group, was significantly higher than 80.00% of the control group, the differences was statistically significant (P<0.05). There was no significant difference in DBIL, TBIL, ALT, AST and other indicators between the two groups before treatment (P>0.05); after treatment, DBIL, TBIL, ALT, AST and other indicators in the study group were significantly lower than those in the control group, the differences were statistically significant (P<0.05). No serious adverse reaction occurred in the two groups, and the incidence of adverse reactions in the study group compared with that in the control group, there was no significant difference (P>0.05). Conclusion: Ursodeoxycholic Acid can effectively improve the therapeutic effect and promote the recovery of liver function in infant cholestasis, which is safe and reliable and worthy of clinical promotion.

[Key words] Ursodeoxycholic Acid Infant Cholestasis Therapeutic effect

First-authors address: Quanzhou Childrens Hospital, Quanzhou 362017, China

胆汁淤积症是一种常见的儿科疾病,在我国小儿肝病住院患儿中居第一位,主要是由于肝细胞损伤或肝内外胆管阻塞导致的胆汁无法排出,临床症状主要有黄疸、皮肤瘙痒、肝脾肿大、肝功能异常等[1]。该病致病因素较多,预后各不相同,若治疗不及时会对患儿的生长发育带来严重影响,甚至可能发展为肝硬化导致患儿死亡[2]。目前临床上治疗胆汁淤积症尚无特异性药物,针对性药物较少,有部分药物还会有多种不良反应,不适用于婴儿,因此婴儿胆汁淤积症治疗难度较大,如何找到一种有效的治疗办法一直是临床研究的重点[3]。熊去氧胆……

登录APP查看全文

猜你喜欢

治疗效果
养阴活血合剂治疗慢性萎缩性胃炎64例临床观察
氧气驱动雾化吸入治疗在小儿中重度急性喉炎中治疗及护理效果
三维适形放射治疗联合卡培他滨化疗治疗晚期直肠癌的疗效观察
经皮椎体成形术中骨水泥使用量与疗效的关系探讨
小切口治疗阑尾炎病人的应用与观察
胃溃疡通过西药联合加味补中益气汤治疗的临床效果分析
比较胸腔镜与开胸手术治疗早期非小细胞肺癌的临床治疗效果
左旋咪唑治疗复发性口腔溃疡36临床观察
心脑血管动脉硬化症的中医治未病临床研究
急性重症胰腺炎80例临床治疗分析